Your browser doesn't support javascript.
Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects.
Sushentseva, N N; Popov, O S; Polkovnikova, I A; Al'pako, S V; Shcherbak, S G.
  • Sushentseva NN; St. Petersburg City Hospital No. 40, Sestroretsk, Russia. navicula@yandex.ru.
  • Popov OS; St. Petersburg City Hospital No. 40, Sestroretsk, Russia.
  • Polkovnikova IA; St. Petersburg City Hospital No. 40, Sestroretsk, Russia.
  • Al'pako SV; St. Petersburg City Hospital No. 40, Sestroretsk, Russia.
  • Shcherbak SG; St. Petersburg City Hospital No. 40, Sestroretsk, Russia.
Bull Exp Biol Med ; 173(1): 133-138, 2022 May.
Article in English | MEDLINE | ID: covidwho-1872575
ABSTRACT
We studied the differences in the characteristics of T-cell immunity in clinically healthy volunteers of three groups "no previous COVID-19, not vaccinated", "recovered", and "vaccinated" as well as the relationship between the presence of IFNγ-releasing T cells in response to stimulation with peptide pools overlapping the main S, N, M, ORF3, and ORF7 protein sequences and the presence of IgG to the SARS-CoV-2 S protein. In the "no previous COVID-19, non-vaccinated" group, T cells specific to both S protein and other virus proteins were absent in 95% subjects. In the "recovered from COVID-19" group, T cells specific to the spike protein were present in samples from 39% subjects. In the same group, T-cell immunity to other viral proteins was present in 58% subjects. In vaccinated subjects, specific T cells responding to stimulation with S protein peptides were found in 47% cases and Т cells specific to N, M, ORF3, ORF7 proteins were detected in only 22% subjects.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Bull Exp Biol Med Year: 2022 Document Type: Article Affiliation country: S10517-022-05508-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Bull Exp Biol Med Year: 2022 Document Type: Article Affiliation country: S10517-022-05508-0